We are a research-based healthcare company dedicated to early detection of dementia, started by two young enthusiastic scientists and entrepreneurs at the University of Cambridge.
Dementia is a progressive brain disorder that affects important functionalities of the brain. It may cause memory loss, mood changes and communication problems. The most common type of dementia is Alzheimer's disease.
It does not have to be a natural part of growing old.
Early diagnosis of dementia allows patients:
Dementia is the sixth leading cause of death in the USA. Current diagnosis is slow, not easily accessible and expensive.
Our inexpensive, widely accessible, and objective solution is perfectly placed to cover the gap by proactively measuring mass population and identifying those with declining cognition.
Ideally, people at the risk of dementia should receive medication before the onset of any cognitive symptoms. Yet the tools that can reveal the first expression of the disease were absent.
At Diamentech we have developed a computerised task that allows for monitoring the activity of millions of networked neurons in related areas of the brain, and so to detect the disease in its early stages. With the current work we envisage being able to detect the disease even before the onset of memory loss symptoms.
Mathys & Squire are intellectual property attorneys specialising in patents, trade marks and designs
ideaSpace, part of the University of Cambridge Hauser Forum, is a hub for early stage innovation
TTP is Europe's leading independent technology development company.
ARM is the world's leading semiconductor intellectual property supplier from a Cambridge UK HQ